Take Solutions Ltd.
Snapshot View

View in App

Prices View details

24.10 +0.40 ▲1.7%

20 May 2022, 04:01:00 PM
Volume: 69,503

Overview View Details

Financial Indicators Consolidated Standalone
Sector	Information Technology	Compare with Sector peers
Industry	IT - Software	Compare with Industry peers
Website	http://www.takesolutions.com
Market Cap	356.52 Cr.
Enterprise Value(EV)	765.01 Cr.	2021-09
Earnings per share (EPS)	-8.25	Trailing Twelve Months Ending 2021-12
Price-Earning Ratio (PE)	-	Trailing Twelve Months Ending 2021-12
Industry PE	27.39	Trailing Twelve Months Ending 2021-12
Book Value / Share	71.67	Trailing Twelve Months Ending 2021-12
Price to Book Value	0.34	Calculated using Price: 24.10
Dividend Yield	0.00	Period Ending 2021-03
No. of Shares Subscribed	14.79 Cr.	147,934,000 Shares
FaceValue	1
Company Profile
TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Business area of the company The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums. Products and services Life Sciences: Life sciences home: implementation of clinical data standards for sponsor process enhancement and preparation of compliant clinical data. Services focused on leveraging the standardization process into Clinical Study and Summary (ISS/ISE) reports. Clinical data offerings: SDTM consultation and Full clinical data lifecycle services, from CRF design to ISS/ISE. Regulatory offerings: PharmaReady, an exclusive brand of TAKE Solutions, is a fully integrated web-based eDMS and eCTD Submissions Solution Suite. Drug safety offerings: Complete Pharmacovigilance Safety System and Clinical Trials Safety Surveillance. Supply Chain Management: Demand Driven Supply Network Demand Driven Distribution & Fulfillment Mobile Applications & Auto-ID Global Trade Management Company’s technology products and solutions are: Business Process Management Solutions- TAKE RTE (real time enterprise) TAKE BI Solutions, the Business Intelligence practice of TAKE Solutions, delivers custom solutions that enable companies to tap the full potential of their business capabilities by helping them access, analyze and share information anytime and anywhere. Microsoft solutions Enterprise desktop management solutions Awards 2008: Recognized by Deloitte as India’s 10th fastest growing technology company 2009: Listed in Food Logistics magazine’s FL 100+ Software & Technology Providers list for third consecutive year 2010: Received MMA (Madras Management Association) award for Managerial Excellence 2010 in the Services category 2010: Recognized by Supply Chain Brain as a Great Supply Chain Partner 2010 for fourth consecutive year 2012: Recognized for “Significant Contribution to SCM field” at Spectrum Confluence 2012 organized by Indian Institute of Materials Management (IIMM) Chennai 2012: Listed on the 2012 Supply and Demand Chain Executive 100 List for the second consecutive year 2012: Recognized as TOP 100 Logistics IT Providers by Inbound Logistics magazine 2013: Emerged as Asia’s Second Best Employer Brand. Declared as Best among 30 Companies from across 33 countries in Singapore 2013: Recognized by Supply Chain Brain’s “2012 Great Supply Chain Partner” list 2013: Named in Software Magazine’s 30th Annual Software 500 as one of the world’s largest software and service companies 2013: Ranked by Inc. India magazine as one of India’s fastest growing top 500 mid-size companies 2014: Won the Best Employer Brand Award at the World HRD Congress, with a total of 14 award wins 2014: Named in 2013 Supply and Demand Chain Executive 100 2014: Listed in Software Magazine’s 31st ‘Annual Software 500’ ranking for the second consecutive year 2015: Ranked 2nd as the Dream Employer of Year, in Technology, at the World HRD Congress, with a total of 16 award wins 2015: Named in Software Magazine’s 32nd Annual Software 500 ranking of the world’s largest software and service providers for the third consecutive year 2016: Received a Special Commendation for Excellence in Corporate Governance at the Golden Peacock Awards 2016: Declared ‘HR Company of the Year’ from amongst over 400 companies at the World HRD Congress 2016: Adjudged the ‘Most Admired Brand – IT’ at the 5th Asian Customer Engagement Forum Awards that recognize excellence in Branding, Marketing and CSR 2017: Received the Golden Peacock Award for Excellence in Corporate Governance 2017: Chosen as one of the ‘Great Places to Work’ for its exemplary workplace culture 2017: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance 2017: Received awards for the ‘Most Effective Campaign’, “Best use of video content’ and ‘Best Media Relations/PR at the prestigious Asian Customer Engagement Forum Awards 2017: Received titles of ‘Dream Company to Work For’ and ‘Best Employer Brand’, and 27 other titles at the World HRD Congress 2018: Won the award for Best Employer Brand for the 2nd consecutive year at the World HRD Congress 2018, and ranked 3rd in the Times Ascent presents Dream Companies to Work For category 2018: Earned a place in the Great Place to Work global listing, the global authority on building, sustaining & recognizing exemplary workplace culture and best practices 2018: Bestowed with the Golden Peacock Award for Excellence in Corporate Governance, for the 2nd consecutive year in 2018 2019: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance 2020: CEO Insights Top 10 Clinical Trials Service Providers - 2020 Milestones 2000-2004 Inaugurated North American headquarters at Princeton, New Jersey, USA TAKE Solutions was founded in Chennai, India 2007-2010 Inaugurated a state-of-the-art global delivery center in Chennai, India Acquired OnSphere Corporation, Raleigh, North Carolina, USA, an IP-driven leader in regulatory compliance for Life Sciences Launched OneSCM, a multi-tenant SaaS platform to improve enterprise supplier management Acquired ClearOrbit, a Supply Chain Management software company in Austin, Texas, USA Registered a successful IPO and listed on the Bombay Stock Exchange and the National Stock Exchange in India. 2011-2014 Recognized as a leader in IDC MarketScape on Drug Safety Services Worldwide Life Science Drug Safety Services 2013 Vendor Assessment Acquired UK-based WCI Consulting Group, a leading patient safety and compliance advisor to the Life Sciences industry Launched SafetyReady to increase the efficiency of Oracle Argus Safety Suite for Life Sciences Recognized as a Leader in IDC MarketScape: Worldwide Life Sciences R&D IT Outsourcing 2011 2015 Launched cdsnet, a proprietary industry network on Clinical Data Strategy Launched Latin American Regulatory Operations Hub in Bogota, Columbia Awarded patent by the United States Patent and Trademark Office (USPTO) for “Method for Optimizing Clinical Data Standardization” Launched India’s first propriety industry network on pharmacovigilance, pvindia Launched pharmaReady 6.0, an update to proprietary web-based electronic document management and eSubmission solution for Life Sciences 2016 Acquired Ecron Acunova, a full-service CRO with Clinical & BA/BE capabilities 100th pharmaReady customer win 2017 Navitas Life Sciences named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment Consolidated Life Sciences businesses under the brand Navitas Life Sciences to provide full services across Clinical, Regulatory and Safety Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences Celebrated the landmark 15th year of its proprietary Life Sciences industry network forums Updated and significantly expanded OneSCM Supply Chain Collaboration Suite Launched the Gemini Series Android App for Smartphones 2018 Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies Navitas Life Sciences recognized as ‘Leader’ in the IDC MarketScape: Drug Safety Services 2018 Vendor Assessment as one of only 8 vendors selected based on stringent research and due diligence Expanded operations in Colombia to offer full-service clinical, regulatory and pharmacovigilance/safety and technology offerings across Latin America Gartner recognized the Company amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies TAKE recognised in CIO Review’s ‘20 Most Promising Pharma and Life Sciences Tech Companies' Inaugurated state-of-the-art Clinical facility in Chennai to conduct Bioavailability & Bioequivalence studies 2019-20 Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research Acquired DataCeutics, an American Clinical Data Sciences services company that provides quality SAS based statistical programming, clinical reporting and clinical data management 175+ customers for pharmaREADY, its cloud-based Regulatory Submissions management platform

Take Solutions Ltd.

TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.

With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange.

Business area of the company

The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.

Products and services

Life Sciences:

Life sciences home: implementation of clinical data standards for sponsor process enhancement and preparation of compliant clinical data. Services focused on leveraging the standardization process into Clinical Study and Summary (ISS/ISE) reports.
Clinical data offerings: SDTM consultation and Full clinical data lifecycle services, from CRF design to ISS/ISE.
Regulatory offerings: PharmaReady, an exclusive brand of TAKE Solutions, is a fully integrated web-based eDMS and eCTD Submissions Solution Suite.
Drug safety offerings: Complete Pharmacovigilance Safety System and Clinical Trials Safety Surveillance.

Supply Chain Management:

Demand Driven Supply Network
Demand Driven Distribution & Fulfillment
Mobile Applications & Auto-ID
Global Trade Management

Company’s technology products and solutions are:

Business Process Management Solutions- TAKE RTE (real time enterprise)
TAKE BI Solutions, the Business Intelligence practice of TAKE Solutions, delivers custom solutions that enable companies to tap the full potential of their business capabilities by helping them access, analyze and share information anytime and anywhere.
Microsoft solutions
Enterprise desktop management solutions

Awards

2008: Recognized by Deloitte as India’s 10th fastest growing technology company
2009: Listed in Food Logistics magazine’s FL 100+ Software & Technology Providers list for third consecutive year
2010: Received MMA (Madras Management Association) award for Managerial Excellence 2010 in the Services category
2010: Recognized by Supply Chain Brain as a Great Supply Chain Partner 2010 for fourth consecutive year
2012: Recognized for “Significant Contribution to SCM field” at Spectrum Confluence 2012 organized by Indian Institute of Materials Management (IIMM) Chennai
2012: Listed on the 2012 Supply and Demand Chain Executive 100 List for the second consecutive year
2012: Recognized as TOP 100 Logistics IT Providers by Inbound Logistics magazine
2013: Emerged as Asia’s Second Best Employer Brand. Declared as Best among 30 Companies from across 33 countries in Singapore
2013: Recognized by Supply Chain Brain’s “2012 Great Supply Chain Partner” list
2013: Named in Software Magazine’s 30th Annual Software 500 as one of the world’s largest software and service companies
2013: Ranked by Inc. India magazine as one of India’s fastest growing top 500 mid-size companies
2014: Won the Best Employer Brand Award at the World HRD Congress, with a total of 14 award wins
2014: Named in 2013 Supply and Demand Chain Executive 100
2014: Listed in Software Magazine’s 31st ‘Annual Software 500’ ranking for the second consecutive year
2015: Ranked 2nd as the Dream Employer of Year, in Technology, at the World HRD Congress, with a total of 16 award wins
2015: Named in Software Magazine’s 32nd Annual Software 500 ranking of the world’s largest software and service providers for the third consecutive year
2016: Received a Special Commendation for Excellence in Corporate Governance at the Golden Peacock Awards
2016: Declared ‘HR Company of the Year’ from amongst over 400 companies at the World HRD Congress
2016: Adjudged the ‘Most Admired Brand – IT’ at the 5th Asian Customer Engagement Forum Awards that recognize excellence in Branding, Marketing and CSR
2017: Received the Golden Peacock Award for Excellence in Corporate Governance
2017: Chosen as one of the ‘Great Places to Work’ for its exemplary workplace culture
2017: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
2017: Received awards for the ‘Most Effective Campaign’, “Best use of video content’ and ‘Best Media Relations/PR at the prestigious Asian Customer Engagement Forum Awards
2017: Received titles of ‘Dream Company to Work For’ and ‘Best Employer Brand’, and 27 other titles at the World HRD Congress
2018: Won the award for Best Employer Brand for the 2nd consecutive year at the World HRD Congress 2018, and ranked 3rd in the Times Ascent presents Dream Companies to Work For category
2018: Earned a place in the Great Place to Work global listing, the global authority on building, sustaining & recognizing exemplary workplace culture and best practices
2018: Bestowed with the Golden Peacock Award for Excellence in Corporate Governance, for the 2nd consecutive year in 2018
2019: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
2020: CEO Insights Top 10 Clinical Trials Service Providers - 2020

Milestones

2000-2004

Inaugurated North American headquarters at Princeton, New Jersey, USA
TAKE Solutions was founded in Chennai, India

2007-2010

Inaugurated a state-of-the-art global delivery center in Chennai, India
Acquired OnSphere Corporation, Raleigh, North Carolina, USA, an IP-driven leader in regulatory compliance for Life Sciences
Launched OneSCM, a multi-tenant SaaS platform to improve enterprise supplier management
Acquired ClearOrbit, a Supply Chain Management software company in Austin, Texas, USA
Registered a successful IPO and listed on the Bombay Stock Exchange and the National Stock Exchange in India.

2011-2014

Recognized as a leader in IDC MarketScape on Drug Safety Services Worldwide Life Science Drug Safety Services 2013 Vendor Assessment
Acquired UK-based WCI Consulting Group, a leading patient safety and compliance advisor to the Life Sciences industry
Launched SafetyReady to increase the efficiency of Oracle Argus Safety Suite for Life Sciences
Recognized as a Leader in IDC MarketScape: Worldwide Life Sciences R&D IT Outsourcing 2011

2015

Launched cdsnet, a proprietary industry network on Clinical Data Strategy
Launched Latin American Regulatory Operations Hub in Bogota, Columbia
Awarded patent by the United States Patent and Trademark Office (USPTO) for “Method for Optimizing Clinical Data Standardization”
Launched India’s first propriety industry network on pharmacovigilance, pvindia
Launched pharmaReady 6.0, an update to proprietary web-based electronic document management and eSubmission solution for Life Sciences

2016

Acquired Ecron Acunova, a full-service CRO with Clinical & BA/BE capabilities
100th pharmaReady customer win

2017

Navitas Life Sciences named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment
Consolidated Life Sciences businesses under the brand Navitas Life Sciences to provide full services across Clinical, Regulatory and Safety
Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences
Celebrated the landmark 15th year of its proprietary Life Sciences industry network forums
Updated and significantly expanded OneSCM Supply Chain Collaboration Suite
Launched the Gemini Series Android App for Smartphones

2018

Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies
Navitas Life Sciences recognized as ‘Leader’ in the IDC MarketScape: Drug Safety Services 2018 Vendor Assessment as one of only 8 vendors selected based on stringent research and due diligence
Expanded operations in Colombia to offer full-service clinical, regulatory and pharmacovigilance/safety and technology offerings across Latin America
Gartner recognized the Company amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies
TAKE recognised in CIO Review’s ‘20 Most Promising Pharma and Life Sciences Tech Companies'
Inaugurated state-of-the-art Clinical facility in Chennai to conduct Bioavailability & Bioequivalence studies

2019-20

Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender
Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research
Acquired DataCeutics, an American Clinical Data Sciences services company that provides quality SAS based statistical programming, clinical reporting and clinical data management
175+ customers for pharmaREADY, its cloud-based Regulatory Submissions management platform

Delivery View Details

Delivered Qty

Traded Qty

Performance View Details

1 Day		+1.69%
1 Week		+8.56%
1 Month		-20.72%
3 Month		-31.44%
6 Month		-48.12%
1 Year		-65.15%
2 Year		-52.70%
5 Year		-81.60%
10 Year		-17.61%

Ratios View Details

	9 years	2013-03	2014-03	2015-03	2016-03	2017-03	2018-03	2019-03	2020-03	2021-03
Return on Equity (%)		23.38	13.88	16.08	21.61	19.05	14.37	12.61	-0.71	-33.61
Return on Capital Employed (%)		21.14	11.84	13.91	18.78	17.74	14.91	13.21	1.38	-21.14
Return on Assets (%)		11.30	7.27	8.96	11.69	11.32	9.96	8.55	-0.46	-20.98

Particulars	10 years	2013-03 Rs. Cr.	2014-03 Rs. Cr.	2015-03 Rs. Cr.	2016-03 Rs. Cr.	2017-03 Rs. Cr.	2018-03 Rs. Cr.	2019-03 Rs. Cr.	2020-03 Rs. Cr.	2021-03 Rs. Cr.	2021-09* Rs. Cr.
Shh. Funds		420	470	524	631	911	1,328	1,518	1,575	1,125	1,117
Non Curr. Liab.		113	82	26	99	81	89	80	219	178	151
Curr. Liab.		258	262	316	443	336	415	724	660	524	571
Minority Int.		46	48	56	40	42	8	9	10	0	0
Equity & Liab.		837	862	922	1,214	1,369	1,840	2,331	2,464	1,826	1,838
Non Curr. Assets		376	401	397	587	590	662	1,159	1,266	965	956
Curr. Assets		460	461	525	626	779	1,178	1,172	1,199	861	882
Misc. Exp. not W/O
Total Assets		837	862	922	1,214	1,369	1,840	2,331	2,464	1,826	1,838

Profit Loss View Details

Consolidated
Standalone

Particulars	10 years	2013-03 Rs. Cr.	2014-03 Rs. Cr.	2015-03 Rs. Cr.	2016-03 Rs. Cr.	2017-03 Rs. Cr.	2018-03 Rs. Cr.	2019-03 Rs. Cr.	2020-03 Rs. Cr.	2021-03 Rs. Cr.	2021-12 Rs. Cr. TTM
Net Sales		832	816	730	1,030	1,345	1,587	2,039	2,213	777	835
Other Income		7	6	8	21	13	6	11	26	12	14
Total Income		839	822	739	1,051	1,357	1,594	2,050	2,239	789	849
Total Expenditure		-671	-668	-620	-866	-1,082	-1,281	-1,656	-2,044	-847	-756
PBIDT		168	153	118	185	275	313	394	195	-58	94
Interest		-14	-14	-13	-15	-23	-21	-25	-41	-37	-36
Depreciation		-46	-77	-20	-25	-87	-104	-154	-167	-115	-102
Taxation		-18	-1	-5	-20	-19	-28	-37	2	-14	-10
Exceptional Items										-225	-68
PAT		89	62	80	125	146	160	178	-11	-450	-122
Minority Interest		-10	-4	-10	-5	-3	1	-1	-1	-2	0
Share Associate
Other Related Items
Consolidated Net Profit		79	58	70	120	143	160	177	-12	-452	-122
Adjusted EPS		7	5	6	10	11	11	12	-1	-31	-8

Cash Flow View Details

Consolidated
Standalone

Particulars	10 years	2012-03 Rs. Cr.	2013-03 Rs. Cr.	2014-03 Rs. Cr.	2015-03 Rs. Cr.	2016-03 Rs. Cr.	2017-03 Rs. Cr.	2018-03 Rs. Cr.	2019-03 Rs. Cr.	2020-03 Rs. Cr.	2021-03 Rs. Cr.
Cash Fr. Operatn.		115	117	100	74	148	56	121	104	211	135
Cash Fr. Inv.		-81	-70	-91	-16	-257	-129	-179	-485	-236	-57
Cash Fr. Finan.		-21	-31	-7	-11	114	56	302	100	21	-84
Net Change		13	16	2	46	5	-17	244	-281	-4	-6
Cash & Cash Eqvt		54	70	72	121	91	74	317	47	45	39

Shareholding Pattern View Details

	9 Qtrs	2020-03 (%)	2020-06 (%)	2020-09 (%)	2020-12 (%)	2021-03 (%)	2021-06 (%)	2021-09 (%)	2021-12 (%)	2022-03 (%)
Promoter		66.89	58.65	53.41	53.41	53.41	53.41	53.41	53.41	53.41
Public		33.11	41.35	46.59	46.59	46.59	46.59	46.59	46.59	46.59
Depository Receipts		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Promoter Holding Pledge (%)		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Announcements View Details

Fri, 20 May 2022
Board Meeting Intimation for Notice Of Board Meeting
TAKE SOLUTIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve the Audited Financial results for the fourth quarter and financial year ended March 31 2022.

Fri, 13 May 2022
Re-Appointment Of Independent Director Of The Company
This is to inform that the Board of Directors of the Company in its meeting held on Friday May 13 2022 approved the re-appointment of Mr. Venkataraman Murali as an Independent Director of the Company with effect from 18th May 2022 for a period of five years subject to approval of the Shareholders.

Sat, 07 May 2022
Intimation Of Action By Deloitte & Touche LLP (Receivers) Dated 6Th May 2022 With Respect To Shares Held By TAKE Solutions Ltd ('The Company') In TAKE Solutions Global Holdings Pte Ltd Singapore Under Regulation 30 Of The SEBI (LODR) Regulations 2015 Read With SEBI Circular CIR/CFD/CMD/4/2015 Dated September 09 2015.
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09 2015 regarding intimation of action by Deloitte & Touche LLP (Receivers) dated 6th May 2022 with respect to Shares held by TAKE Solutions Ltd (the Company) in TAKE Solutions Global Holdings Pte Ltd Singapore is enclosed herewith.

Technical Scans View Details

Fri, 20 May 2022

Closing Above Previous High

High Decrease 1 Month

High Decrease 3 Months

High Decrease 6 Months

High Decrease 1 Year

Related Stocks View Details

Stock Name	Market Cap(Rs. Cr.)	LTP	Chg %
Tata Consultancy Services Ltd.	1,205,254.93	3,293.90	+0.7%
Infosys Ltd.	612,393.52	1,455.50	+2.0%
HCL Technologies Ltd.	279,127.59	1,028.60	+1.9%
Wipro Ltd.	251,963.29	459.60	+1.8%
Tech Mahindra Ltd.	110,322.27	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	70,863.22	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	69,829.06	1,472.55	+0.4%

Market Cap(Rs. Cr.)
Tata Consultancy Services Ltd.	1,205,254.93	3,293.90 +0.7%
Infosys Ltd.	612,393.52	1,455.50 +2.0%
HCL Technologies Ltd.	279,127.59	1,028.60 +1.9%
Wipro Ltd.	251,963.29	459.60 +1.8%
Tech Mahindra Ltd.	110,322.27	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd.	70,863.22	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd.	69,829.06	1,472.55 +0.4%

Stock Name	Statement	TTM Ending	Price Earning Ratio(TTM)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	31.45	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	27.70	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2022-03	20.68	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	20.62	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2022-03	19.82	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2022-03	30.85	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	0.00	1,472.55	+0.4%

Price Earning Ratio(TTM)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	31.45	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	27.70	1,455.50 +2.0%
HCL Technologies Ltd. 2022-03 \| Consolidated	20.68	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	20.62	459.60 +1.8%
Tech Mahindra Ltd. 2022-03 \| Consolidated	19.82	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2022-03 \| Consolidated	30.85	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	0.00	1,472.55 +0.4%

Stock Name	Statement	TTM Ending	Price To Book Value(TTM)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	13.60	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	8.19	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2022-03	4.51	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	3.86	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2022-03	4.10	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2022-03	8.03	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	11.64	1,472.55	+0.4%

Price To Book Value(TTM)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	13.60	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	8.19	1,455.50 +2.0%
HCL Technologies Ltd. 2022-03 \| Consolidated	4.51	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	3.86	459.60 +1.8%
Tech Mahindra Ltd. 2022-03 \| Consolidated	4.10	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2022-03 \| Consolidated	8.03	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	11.64	1,472.55 +0.4%

Stock Name	Statement	Year Ending	Debt Equity Ratio	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	0.00	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	0.00	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2021-03	0.07	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	0.23	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2021-03	0.07	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2021-03	0.01	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	0.39	1,472.55	+0.4%

Debt Equity Ratio
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	0.00	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	0.00	1,455.50 +2.0%
HCL Technologies Ltd. 2021-03 \| Consolidated	0.07	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	0.23	459.60 +1.8%
Tech Mahindra Ltd. 2021-03 \| Consolidated	0.07	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2021-03 \| Consolidated	0.01	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	0.39	1,472.55 +0.4%

Stock Name	Statement	Year Ending	Return On Equity(%)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	44.13	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	29.39	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2021-03	20.09	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	20.40	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2021-03	19.01	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2021-03	30.79	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	15.56	1,472.55	+0.4%

Return On Equity(%)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	44.13	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	29.39	1,455.50 +2.0%
HCL Technologies Ltd. 2021-03 \| Consolidated	20.09	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	20.40	459.60 +1.8%
Tech Mahindra Ltd. 2021-03 \| Consolidated	19.01	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2021-03 \| Consolidated	30.79	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	15.56	1,472.55 +0.4%

Stock Name	Statement	Year Ending	Return On Capital Employed(%)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	44.13	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	29.39	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2021-03	20.09	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	20.40	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2021-03	19.01	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2021-03	30.79	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	15.56	1,472.55	+0.4%

Return On Capital Employed(%)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	44.13	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	29.39	1,455.50 +2.0%
HCL Technologies Ltd. 2021-03 \| Consolidated	20.09	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	20.40	459.60 +1.8%
Tech Mahindra Ltd. 2021-03 \| Consolidated	19.01	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2021-03 \| Consolidated	30.79	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	15.56	1,472.55 +0.4%

Stock Name	Statement	Year Ending	Net Sales(Rs. Cr.)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	191,754.00	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	121,641.00	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2021-03	75,379.00	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	79,312.00	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2021-03	37,855.10	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2021-03	12,369.80	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	2,440.89	1,472.55	+0.4%

Net Sales(Rs. Cr.)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	191,754.00	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	121,641.00	1,455.50 +2.0%
HCL Technologies Ltd. 2021-03 \| Consolidated	75,379.00	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	79,312.00	459.60 +1.8%
Tech Mahindra Ltd. 2021-03 \| Consolidated	37,855.10	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2021-03 \| Consolidated	12,369.80	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	2,440.89	1,472.55 +0.4%

Stock Name	Statement	Year Ending	Profit After Tax(Rs. Cr.)	LTP	Chg %
Tata Consultancy Services Ltd.	Consolidated	2022-03	38,449.00	3,293.90	+0.7%
Infosys Ltd.	Consolidated	2022-03	22,146.00	1,455.50	+2.0%
HCL Technologies Ltd.	Consolidated	2021-03	11,169.00	1,028.60	+1.9%
Wipro Ltd.	Consolidated	2022-03	12,227.20	459.60	+1.8%
Tech Mahindra Ltd.	Consolidated	2021-03	4,351.80	1,134.95	+2.4%
Larsen & Toubro Infotech Ltd.	Consolidated	2021-03	1,938.20	4,042.25	+1.4%
FSN E-Commerce Ventures Ltd.	Consolidated	2021-03	61.65	1,472.55	+0.4%

Profit After Tax(Rs. Cr.)
Tata Consultancy Services Ltd. 2022-03 \| Consolidated	38,449.00	3,293.90 +0.7%
Infosys Ltd. 2022-03 \| Consolidated	22,146.00	1,455.50 +2.0%
HCL Technologies Ltd. 2021-03 \| Consolidated	11,169.00	1,028.60 +1.9%
Wipro Ltd. 2022-03 \| Consolidated	12,227.20	459.60 +1.8%
Tech Mahindra Ltd. 2021-03 \| Consolidated	4,351.80	1,134.95 +2.4%
Larsen & Toubro Infotech Ltd. 2021-03 \| Consolidated	1,938.20	4,042.25 +1.4%
FSN E-Commerce Ventures Ltd. 2021-03 \| Consolidated	61.65	1,472.55 +0.4%

Take Solutions Ltd. Snapshot View